First volunteer vaccinated in the world's first Bundibugyo ebolavirus vaccine trial...Read more
Gates Medical Research Institute and SII Reach Agreement for the Manufacture of M72/AS01E Tuberculosis Vaccine Candidate, Pending Successful Phase 3 Outcomes...Read more
World’s first Phase I Bundibugyo ebolavirus vaccine trial launched by Oxford Vaccine Group...Read more
